Iron-based absorbable and implantable medical device and manufacturing method thereof
Provided are an iron-based absorbable and implantable medical device and manufacturing method thereof. The iron-based absorbable and implantable medical device ( 1 ) comprises a substrate ( 11 ), a degradable polymer layer ( 12 ), and an anionic surfactant layer ( 13 ) located between the substrate ( 11 ) and the degradable polymer layer ( 12 ). The anionic surfactant, by using the hydrophobicity thereof, can form a hydrophobic barrier layer in a solution to isolate a surface of the iron-based substrate ( 11 ) from a body fluid environment, thereby avoiding direct contact with an acidic environment resulting from degradation of the degradable polymer layer ( 12 ) at the initial and early stages of implantation, thus preventing severe local corrosion of the iron-based substrate ( 11 ).
1. An iron-based absorbable and implantable medical device, comprising an iron-based substrate and a degradable polymer layer, wherein the implantable medical device further comprises an anionic surfactant layer located between the substrate and the degradable polymer layer; wherein the iron-based absorbable and implantable medical device further comprises an intermediate layer located between the substrate and the anionic surfactant layer; wherein the intermediate layer is a rough surface of the iron-based substrate, an iron oxide compound layer, or an iron phosphate compound layer; and wherein the anionic surfactant layer is absorbed to the iron present in the substrate and/or the intermediate layer.
2. The iron-based absorbable and implantable medical device according to claim 1 , wherein the anionic surfactant present in the anionic surfactant layer is absorbed by the substrate by chemical adsorption.
3. The iron-based absorbable and implantable medical device according to claim 1 , wherein the anionic surfactant in the anionic surfactant layer comprises a hydrophilic group and hydrophobic chain, wherein the hydrophilic group is a polar hydrophilic group, and the hydrophobic chain is a non-polar hydrophobic chain.
4. The iron-based absorbable and implantable medical device according to claim 3 , wherein the hydrophilic group is selected from at least one of carboxylic acid group, sulfate group or sulfonate group.
5. The iron-based absorbable and implantable medical device according to claim 3 , wherein the hydrophobic chain comprises a hydrocarbon chain, the hydrocarbon chain comprising at least 8 carbon atoms.
6. The iron-based absorbable and implantable medical device according to claim 1 , wherein the anionic surfactant is selected from at least one of sodium dodecyl sulphate, sodium dodecyl sulfonate, or sodium dodecyl benzene sulfonate.
7. The iron-based absorbable and implantable medical device according to claim 3 , wherein the anionic surfactant layer comprises a single hydrophilic group layer or several hydrophilic group layers.
8. The iron-based absorbable and implantable medical device according to claim 1 , wherein the anionic surfactant present in the anionic surfactant layer is absorbed to the iron present in the intermediate layer.
9. The iron-based absorbable and implantable medical device according to claim 1 , wherein the degradable polymer layer is mixed with an active drug, and the active drug comprises anti-hyperplasia drug, antiplatelet drug, antithrombotic drug, anti-inflammatory response drug, or a mixture of at least two of the drugs.
10. The iron-based absorbable and implantable medical device according to claim 9 , wherein the anti-hyperplasia drug comprises paclitaxel, and rapamycin; the anti-platelet drug comprises cilostazol; the anti-thrombotic drug comprises heparin; and the anti-inflammatory drug comprises dexamethasone.
11. The iron-based absorbable and implantable medical device according to claim 1 , wherein the anionic surfactant present in the anionic surfactant layer is absorbed to the iron present in the substrate.